chrisvoncsefalvay/vaers-outcomes huggingface dataset:
he received MMR II when he was a kid but his titers were low so he went to get re-vaccinated.; a dose of MMR II given IM in the deltoid instead of SQ.; This spontaneous report has been received from a male patient of unknown age, reporting on himself. The patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications were not reported.  On an unknown date (reported as "when he was a kid"), the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose, lot #, expiration date, route of administration and anatomical location were not provided) as prophylaxis.  On an unknown date, his titers were low (unspecified test) (antibody test abnormal), due to this, he went to get revaccinated, and on an unknown date, the patient received another dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) administered intramuscularly (IM) (incorrect route of product administration) (conflicting information, also reported as "subcutaneous [SQ] instead of IM") in the deltoid region (unspecified side) (dose, lot # and expiration date were not provided) as prophylaxis. The reporter stated the titers would be check again post vaccination. At the time of the report, the outcome for antibody test abnormal was not reported.  The causality assessment between measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and antibody test abnormal was not reported.
Pt recvd vax 18NOV91 @ approx 230-3PM & 530PM devel runny nose, SOB, incoherence & queasiness; 19NOV91 was sl SOB on exertion, yawning & sighing;
Blood in stool, starting day after vaccines lasting for about 1 1/2 weeks, no other problems
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. In 2014 the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 01-MAY-2016, the patient was treated at a medical center, for a blistering vesicular outbreak, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine and/or despite receiving ZOSTAVAX, for long-term prevention of shingles, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Site: Pain at Injection Site-Mild, Additional Details: Continued pain after 28 days, no mobility issues
This is a spontaneous report from a contactable physician. A female patient of an unspecified age received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) at a single dose for immunization and morphine sulfate at an unspecified dose for an unspecified indication; both via an unspecified route of administration on an unspecified date. The patient's medical history and concomitant medications were not reported. It was reported that the patient had drug allergies on pneumococcal vaccine and morphine. The action taken in response to the event for morphine sulfate was unknown. Outcome of the event was unknown. Pfizer is a marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) and morphine sulfate in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) and morphine sulfate has submitted the same report to the regulatory authorities.
Initial report received from a healthcare professional on 08 November 2013. A 14-year-old patient received last year's FLUZONE 0.25 ml. (No information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
couldnt walk; hobbling; muscle pain on his calf; Hurting; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (couldnt walk), GAIT DISTURBANCE (hobbling), PAIN IN EXTREMITY (muscle pain on his calf) and PAIN (Hurting) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced GAIT INABILITY (couldnt walk), GAIT DISTURBANCE (hobbling), PAIN IN EXTREMITY (muscle pain on his calf) and PAIN (Hurting). At the time of the report, GAIT INABILITY (couldnt walk), GAIT DISTURBANCE (hobbling), PAIN IN EXTREMITY (muscle pain on his calf) and PAIN (Hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-098830 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-098830:Reporter's case
after 4th shot while deployed-104 fever, delirious, i.v. administered w/ multiple meds. sick for continuous 3 days after. Current nervous system disorders, weak immune system, repeated throat infections, mouth ulcers. Blood work- hi protein levels, abnormal white count. Constant muscle weakness  like oxygen sucked out of blood, uncontrollable trembling, swollen eyes, extremity cramps, sudden heart palpations,constant loss of memory, severe insomnia, anxiety, restlessness-yet fatigued,slurring speech,blurred vision, constant buzzing/white noise in ears &/or hi-pitched ringing, severe mood swings, loss of bowel control, loosening of teeth, social anxiety, irritablity, tunnel vision,extreme fatigue...most symptoms continue to worsen daily, beginning 2 months after my 5th shot on 14 Feb 2007, excluding the fever in theater, after 4th shot on 04 April 2006 (as listed above). No treatment yet, fear of  losing my civilian job, if they find out these issues. Nerve/muscle damage  Autoimmune symptoms Spine Deterioration
Information has been received from a physician concerning a female who on an unknown date was vaccinated with the first dose of GARDASIL and fainted. Subsequently the patient recovered. The patient since, has received her second and third dose and did not have any more fainting episodes. Additional information has been requested.
Arm he got the vaccine injection in became sore; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm, administration date 27Feb2021 (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 28Feb2021, outcome "unknown", described as "Arm he got the vaccine injection in became sore".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The vaccine did not prevent shingles as intended; herpes zoster or shingles; Information has been received from a lawyer regarding a case in litigation referring to a female patient of unknown age. Information about concurrent condition, medical history and concomitant therapy was not reported. In 2013, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, lot# and expiration date not reported) at a pharmacy, as recommended for routine adult health maintenance and for the long-term prevention of shingles. The vaccine did not prevent shingles and the patient subsequently contracted a persistent strain of herpes zoster or shingles. In 2014, the patient was treated at a hospital, for the onset of a severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the zoster vaccine live (ZOSTAVAX), and/or despite receiving zoster vaccine live (ZOSTAVAX) for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events herpes zoster and vaccination failure was not reported. The lawyer considered the events to be related to zoster vaccine live (ZOSTAVAX).
Shingles in T1 dermatomal distribution involving the right upper extremity (same as vaccine administration site), axilla, chest, and back.
I received the AFLURIA QUAD (2018-2019) Flu Vaccine at a Pharmacy. Manufacturer: Seqirus Inc. The Lot # of the vaccine was YF43109. Volume 0.5 mL. Administered IM in Left Deltoid. Within a couple of minutes a pulsing rainbow aura appeared in my left eye. This was accompanied by loss of peripheral vision on the left side of that eye and a sense of disorientation and dizziness. The aura diminished after 15 minutes and was gone after 45 minutes. Peripheral vision seemed back to normal as well. However, as the aura diminished, I got a headache on the opposite (right) side. Headache persisted for 24 hours (ADVIL helped but did not eliminate it).
Mother reports, red rash right temple, that moved to entire face, with lip and facial swelling.  No respiratory difficulties, no nausea or vomiting.  Rash resolved in 24 hours.
This spontaneous report was received from a nurse refers to unspecified patients of unknown demographics. The patient's concurrent conditions, medical history and drug reactions and allergies was unknown. The patient's concomitant therapies included sterile diluents. On an unknown date, the patient was vaccinated with improperly stored VARIVAX (Lot # N012619 and expiration date 21-APR-2019), (Lot # N025932 and expiration date 19-SEP-2019) and PROQUAD (Lot # N020618 and expiration date 22-JAN-2019), (Lot# N025923 and expiration date 18-MAR-2019) for prophylaxis. Temperature excursion details were provided. Temperature/Time frame was -14 C to -10 C (-14.3 C) for 1 hour 6 minutes. There were no previous temperature excursion. The call was because of a data logger. No adverse effects were reported. There was no product quality compliant reported. Lot number [N012619 and N025932] has been verified to be a valid lot number for [varicella virus vaccine live (oka/merck)]. Lot number [N020618 and N025923] has been verified to be a valid lot number for [measles, mumps, rubella and varicella (oka-merck) virus vaccine live].
Injection Site Pain, tiredness, headache severe, muscle pain, chills, joint pain, fever, nausea, feeling unwell, cough
fever 104 13FEB & 14FEb;devel rash on face, hairline, back of neck, trunk & upper extremities on 15FEB96;saw MD on 20FEB96 was given amoxicillin for ear infect;saw MD again 23FEB96 & was dx roseola;afeb now
At Noon he became lethargic, loss of appetite. A healthy baby went from just that to unable to move on the floor in PAIN. His fever started around noon at 100.3 and crept up to 103.5 degrees by 6 pm. By 6 pm he was still lethrgic and unresponsive his face was bright red and then he began projectile vomiting which he had never done before. As a baby he had never even spit up but twice (I brestfed). And he had only had a few vaccines up until that point, he had not followed the RECCOMMENDED vaccine schedule,whose vaccines were was just recently deemed "unavoidably unsafe". Anyways he did break his fever, and then he slept for far longer than what he usually sleeps and recovered completely.
mmrv given  on right arm with dtap, pt had redness and swelling at site along with varicella rash on arm shot given on 10-16/2007 mother noted rash on 10/17/2007 in afternoon, brought to office on 10/18/2007, dried up with no drainage on 10/19/2007
This report is only in response to the request from the Department of Health to submit all patients into VAERS that received the COVID19 vaccine and subsequently tested positive for COVID19.  No other adverse reactions to the vaccine were reported. This patient tested positive for COVID19 on 12/29/20 after receiving the vaccine on 12/16/2020.
This case was reported by a consumer via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 79-year-old female patient who received SHINGRIX (batch number BF4J5, expiry date 5th July 2021) for prophylaxis. Concomitant products included steroids nos (Steroids). On 2nd March 2019, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In March 2019, 1 day after receiving SHINGRIX, the patient experienced extensive swelling of vaccinated limb (serious criteria other: ER visit), injection site erythema (serious criteria hospitalization), injection site itching (serious criteria hospitalization), burning tongue (serious criteria hospitalization), burning in eyes (serious criteria hospitalization), facial flushing (serious criteria hospitalization) and gastritis (serious criteria hospitalization). The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the extensive swelling of vaccinated limb, injection site erythema, injection site itching, burning tongue, burning in eyes, facial flushing and gastritis were not recovered/not resolved. It was unknown if the reporter considered the extensive swelling of vaccinated limb, injection site erythema, injection site itching, burning tongue, burning in eyes, facial flushing and gastritis to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on the left arm. One to 2 days after vaccination, the patient experienced all the symptoms. The patient experienced redness, swelling (extensive swelling of vaccinated limb), and itching approximately 5 inches in diameter on the skin around the injection site. The patient also experienced slight burning on tongue, burning on both eyes and flushing on face on both cheeks and over nose. The patient received Tylenol daily post-vaccination to suppress symptoms. The patient also received icing for injection site relief. The patient also experienced severe episode of gastritis which required emergency visit approximately 2 weeks after vaccination. The reporter stated she, primary care physician and registered pharmacist unsure if she should receive 2nd dose. The reporter consented to follow up.
[Splitting headache, fever, chills, nausea, vomiting] 12 hrs; [tender and swollen lymph nodes near jaw, sore neck] ongoing.
Massive headache for 8 days.  I believe it was encephalitis.  Dizziness, fatigue, nausea, terrible neck pain,  pain allover skull.  Completely out of it.  Disoriented, Fever, rash, missed work.  Now I have a purple spot on my inside of left leg, found this morning 6/14/21 7:30 am.
"A territory representative reported that a 5 month old female received her 2nd dose of Prevnar along with Hib-Titer, DTAP and IPV vaccines on 2/7/01. On 3/16/01, the infant developed "acute" meningitis. The following day, she was hospitalized. An unspecified culture was positive for Streptococcus pneumonia, serotype unknown.  The infant was treated with Ampicillin and Rocephin (ceftriaxone)." Also diagnosed with anemia.
Foggy head; lots of anxiety; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Lot number was not reported) as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced foggy head, lots of anxiety on an unspecified date. The outcome was unknown.  Pfizer is a marketing authorization holder of BNT162B2 in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of BNT162B2 has submitted the same report to the regulatory authorities.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a consumer concerning her son. One day post vaccination the pt developed an upset stomach.
I did not notice any out of the normal symptoms  one of my kids at work tested positive for covid at work so I decided to go to a free  facility.
Very Sharp pain upper back thoracic area and upper arms like stabbing. Very sharp and excruciating  pain lower part areas around both ears. It starts everyday around 8:30pm . I have to sit or lay down and last about 30 minutes. After that the pain goes down very slightly step by step. Before it starts, I have a big sweat on my head. I feel exhausted. It has been 12 days non stop now and I can not stand it anymore.
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 11-JUN-2018, the patient was inadvertently vaccinated with an expired dose of RECOMBIVAX HB (lot # M033096 with expiration date of 31-MAY-2018; strength, dose, route and anatomical location were not provided), for prophylaxis. No adverse effects reported.
Patient said their arm was so sore they could not lift it and had no range of motion.  Had to have physical therapy.  Will not get the second dose. Did see their physician who sent them to physical therapy.  Can now lift their arm.
In addition to CDC expected symptoms (swelling of the face, tiredness, headache, muscle pain, chills) I also experienced daily nausea, daily dizziness, daily vomiting, occasional sore throat.
TESTED NEGATIVE FOR IGG  ANTIBODIES; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, and batch number: 1805022 expiry: 25-MAY-2021) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the subject experienced tested negative for igg antibodies. Laboratory data (dates unspecified) included: Antibody test (NR: not provided) tested negative for spike specific IgG antibodies at Lab. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of tested negative for igg antibodies was not reported. This report was non-serious.
The pt experienced light headedness, eyes red and teary, throat tightened up. Pt treated with Adrenalin and observed for 1 hour in office.
Spoke to mother of patient on 2/06/23. Patient's mother stated patient had a localized reaction of swelling and induration to one or more of his vaccines administered on 01/20/23. The reaction was characterized by mother as a "large, red mark" on his right thigh. Patient's mother stated the skin was "super irritated" and had a "large red bump". Patient's mother stated that the site was irritated for about 2 days. Patient did not have a fever and patient was acting normally according to patient's mother. Patient's mother stated the site is now "normal" except for the skin having a "texture change" where the "rash" used to be. Patient's mother stated she has no concerns at this time and declined an appointment with a provider to assess the injection site.
Pt felt weak and dopey at dinner and awoke on the floor, incontinent of urine. Pt experienced slight headache and weakness that night. Pt was fully recovered within 48 hours later.
Worsening pain in pelvic and shoulder girdle, worst in early morning and upon awakening, abating during the day. Has lasted for over 1 week. Initiated prednisone 10 mg po qd today
Experiencing burning while urinating; This is a spontaneous report from a contactable consumer (patient who is Nursing assistant).  This 56-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EK5730), via an unspecified route of administration, on 19Dec2020 approximately at 10:00 AM (age at vaccination 56-years-old) at single dose for COVID-19 immunisation. Medical history included blood pressure. Concomitant medications included losartan for blood pressure and colecalciferol (VITAMIN D). The patient experienced burning while urinating on 19Dec2020 afternoon after she came home and on 20Dec2020 morning too. About treatment consumer stated: "Not really, long time ago I had that but yesterday I did like oh".  The patient had complete blood count (CBC) and C-reactive protein (CRP) test, results are unknown. Outcome was not recovered. Next shot is due on 09Jan2021.
Tiredness, then dizziness and chapped lips. Next day, lips are swollen and chapped, still dizzy although less
Headache; Light headedness; This is a spontaneous report from a Pfizer- sponsored program from a non-contactable consumer (patient).   A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date as SINGLE DOSE for covid-19 immunisation.  The patient medical history and the concomitant medications were not reported.  The patient experienced headache, light headedness on an unspecified date. The outcome was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Throat started itching about 20 mins after, then the roof of mouth to a full body itching feeling. Took BENADRYL itching went away to only return in the mouth. Fever of 101.5, and weakness feeling even after 24 hrs.
I experienced severe muscle and joint pain, headache, chills and stomach cramps the evening of October 11, approximately 32 hours after receiving the flu vaccination on October 10 at 8:30 AM. The symptoms started with stomach cramping and progressed into the severe muscle and joint pain, headache and chills shortly after. I had difficulty moving and especially walking as it impacted my knees and legs badly. This lasted for about 6 hours. I contemplated visiting a local urgent care center or emergency room, but I was able to sleep and felt a little better in the morning.
got my PE out of my lung; blood clots; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PULMONARY EMBOLISM (medically significant), described as "got my PE out of my lung"; THROMBOSIS (medically significant), described as "blood clots". It was reported that the emergency room that the patient presented to, transferred the patient from one hospital to another via helicopter and got the patient's PE out of the lung with a hose. Also reported that the patient was plagued with blood clots and had to take Eliquis for the rest of the patient's life. The event "got my pe out of my lung" required emergency room visit. Therapeutic measures were taken as a result of pulmonary embolism, thrombosis. Outcome of the events was unknown.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : 202300034567 Same reporter/patient,diff drug;